Sun Pharmaceutical Industries Ltd - Company Profile
Powered by 
All the sales intelligence you need on Sun Pharmaceutical Industries Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Sun Pharmaceutical Industries Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Sun Pharmaceutical Industries Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Sun Pharmaceutical Industries Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20230391790A1 | Application | Indene derivatives useful in treating pain and inflammation | A61P29/00; C07D231/54; C07D401/08; C07D403/08; C07D417/08; C07D493/10 | December 07, 2023 |
| US20230390292A1 | Application | Regimens for the treatment of hair loss disorders with deuterated jak inhibitors | A61K31/519; A61K9/20; A61P17/14 | December 07, 2023 |
| AU2021203084B2 | Grant | Modified plant | C12N15/8213; C12N15/8218; C12N15/8243; C12N9/0071; C12Y114/11031; C12Y114/11032; A01H5/02; A01H5/10; A01H6/64; C07D489/02 | November 23, 2023 |
| US11819501B2 | Grant | Parenteral unit dosage form of dihydroergotamine | A61K31/48; A61K31/4985; A61K9/0019; A61K9/08; A61M5/20; A61P25/06 | November 21, 2023 |
| US20230364106A1 | Application | Parenteral dosage form of diltiazem | A61K31/554; A61K47/26; A61K9/0029 | November 16, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer